CIRCULATING HUMAN PERIPHERAL-BLOOD GRANULOCYTES SYNTHESIZE AND SECRETE TUMOR NECROSIS FACTOR-ALPHA

被引:282
作者
DUBRAVEC, DB
SPRIGGS, DR
MANNICK, JA
RODRICK, ML
机构
[1] HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT SURG,BOSTON,MA 02115
[2] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DEPT CLIN PHARMACOL,BOSTON,MA 02115
关键词
endotoxin; interleukin; 1; neutrophil;
D O I
10.1073/pnas.87.17.6758
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Circulating peripheral blood polymorphonuclear neutrophils (PMNs) have long been considered terminally differentiated cells that do not synthesize or secrete protein. However, work of others and ourselves has shown that PMNs can secrete the cytokine interleukin 1. In the present study we investigated whether circulating PMNs are capable of synthesizing and secreting another cytokine, tumor necrosis factor α (TNF-α). Highly purified (>99% granulocytes) PMNs were isolated from normal human volunteer blood and cultured with or without bacterial lipopolysaccharide (LPS) for up to 24 hr. Cell culture supernatants were collected and tested for TNF-α, and total RNA was isolated from cells at various times after stimulation and assessed for TNF-α mRNA by Northern blot techniques. The results showed that message for TNF-α was produced after 60 min of in vitro stimulation with LPS and was maximal at about 4 hr. TNF-α was secreted into the supernatant of unstimulated PMNs from two different donors during 24 hr of culture (35-50 pg/ml), but significantly more (160-190 pg/ml) was secreted by PMNs when stimulated with LPS. PMNs from six other normal volunteers showed significant LPS-stimulated secretion of TNF at 60-180 min of culture. The secreted product also had biological activity against the TNF-sensitive L-M cell line, confirming that PMNs can make and secrete immunologically and biologically active TNF. Since it is also possible for monocytes to synthesize and secrete TNF, the amount of TNF secreted by a monocyte population equal to 20% of the PMNs cultured was measured. The results showed that monocytes at a concentration 20 times that potentially contaminating the PMN populations cultured could not produce as much TNF (unstimulated, 26-65 pg/ml; stimulated, 32-87 pg/ml). The PMN must now be considered a cell capable of altering the acute inflammatory response and modulating the immune response through the synthesis and release of cytokines.
引用
收藏
页码:6758 / 6761
页数:4
相关论文
共 19 条
[1]   TUMOR-NECROSIS-FACTOR STIMULATES INTERLEUKIN-1 AND PROSTAGLANDIN-E2 PRODUCTION IN RESTING MACROPHAGES [J].
BACHWICH, PR ;
CHENSUE, SW ;
LARRICK, JW ;
KUNKEL, SL .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 136 (01) :94-101
[2]   DEVELOPMENT OF NEUTROPHILIC POLYMORPHONUCLEAR LEUKOCYTES IN HUMAN BONE MARROW - ORIGIN AND CONTENT OF AZUROPHIL AND SPECIFIC GRANULES [J].
BAINTON, DF ;
ULLYOT, JL ;
FARQUHAR, MG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1971, 134 (04) :907-+
[3]   STIMULATION OF BONE-RESORPTION AND INHIBITION OF BONE-FORMATION INVITRO BY HUMAN-TUMOR NECROSIS FACTORS [J].
BERTOLINI, DR ;
NEDWIN, GE ;
BRINGMAN, TS ;
SMITH, DD ;
MUNDY, GR .
NATURE, 1986, 319 (6053) :516-518
[4]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[5]   GENERATION OF LYMPHOKINE-ACTIVATED KILLER CELLS - SYNERGY BETWEEN TUMOR NECROSIS FACTOR AND INTERLEUKIN-2 [J].
CHOUAIB, S ;
BERTOGLIO, J ;
BLAY, JY ;
MARCHIOLFOURNIGAULT, C ;
FRADELIZI, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (18) :6875-6879
[6]   CACHECTIN TUMOR NECROSIS FACTOR STIMULATES COLLAGENASE AND PROSTAGLANDIN-E2 PRODUCTION BY HUMAN SYNOVIAL-CELLS AND DERMAL FIBROBLASTS [J].
DAYER, JM ;
BEUTLER, B ;
CERAMI, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 162 (06) :2163-2168
[7]   TUMOR-NECROSIS-FACTOR (CACHECTIN) IS AN ENDOGENOUS PYROGEN AND INDUCES PRODUCTION OF INTERLEUKIN-1 [J].
DINARELLO, CA ;
CANNON, JG ;
WOLFF, SM ;
BERNHEIM, HA ;
BEUTLER, B ;
CERAMI, A ;
FIGARI, IS ;
PALLADINO, MA ;
OCONNOR, JV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (06) :1433-1450
[8]  
DUBRAVEC D, 1988, Journal of Dental Research, V67, P151
[9]  
ELIAS JA, 1987, J IMMUNOL, V138, P3812
[10]  
JACK RM, 1988, J IMMUNOL, V140, P4286